These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 6502791)

  • 1. Epigenetic carcinogens: problems with identification and risk estimation.
    Hooper K
    J Toxicol Clin Toxicol; 1984; 22(3):283-9. PubMed ID: 6502791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Types and amounts of carcinogens as potential human cancer hazards.
    Weisburger JH; Williams GM
    Cell Biol Toxicol; 1989 Dec; 5(4):377-91. PubMed ID: 2627674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Threshold and non-threshold chemical carcinogens: A survey of the present regulatory landscape.
    Bevan RJ; Harrison PTC
    Regul Toxicol Pharmacol; 2017 Aug; 88():291-302. PubMed ID: 28119000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distinct health risk analyses required for genotoxic carcinogens and promoting agents.
    Weisburger JH; Williams GM
    Environ Health Perspect; 1983 Apr; 50():233-45. PubMed ID: 6873017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Failure of carcinogenic action of 7-methylguanine in rats].
    Krüger FW; Schmähl D
    Z Krebsforsch; 1971; 75(4):253-4. PubMed ID: 4256490
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemically induced cell proliferation in carcinogenesis.
    Butterworth BE; Popp JA; Conolly RB; Goldsworthy TL
    IARC Sci Publ; 1992; (116):279-305. PubMed ID: 1428087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of carcinogenic quinoline 1-oxides on coding from DNA strands.
    Naora H; Naora H
    Gan; 1966 Oct; 57(5):497-506. PubMed ID: 5968222
    [No Abstract]   [Full Text] [Related]  

  • 8. A combined bacterial and liver test system for detection and classification of carcinogens as mutagens.
    Ames BN
    Genetics; 1974 Sep; 78(1):91-5. PubMed ID: 4613611
    [No Abstract]   [Full Text] [Related]  

  • 9. DNA methylome alterations in chemical carcinogenesis.
    Pogribny IP; Beland FA
    Cancer Lett; 2013 Jun; 334(1):39-45. PubMed ID: 23010082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation, heterochromatin and epigenetic carcinogens.
    Klein CB; Costa M
    Mutat Res; 1997 Apr; 386(2):163-80. PubMed ID: 9113117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
    Gaylor DW
    Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemical carcinogenicity revisited 2: Current knowledge of carcinogenesis shows that categorization as a carcinogen or non-carcinogen is not scientifically credible.
    Doe JE; Boobis AR; Dellarco V; Fenner-Crisp PA; Moretto A; Pastoor TP; Schoeny RS; Seed JG; Wolf DC
    Regul Toxicol Pharmacol; 2019 Apr; 103():124-129. PubMed ID: 30660801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental and chemical carcinogenesis.
    Wogan GN; Hecht SS; Felton JS; Conney AH; Loeb LA
    Semin Cancer Biol; 2004 Dec; 14(6):473-86. PubMed ID: 15489140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormesis and dose-response-mediated mechanisms in carcinogenesis: evidence for a threshold in carcinogenicity of non-genotoxic carcinogens.
    Fukushima S; Kinoshita A; Puatanachokchai R; Kushida M; Wanibuchi H; Morimura K
    Carcinogenesis; 2005 Nov; 26(11):1835-45. PubMed ID: 15975961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Tox21 Approach to Altered Epigenetic Landscapes: Assessing Epigenetic Toxicity Pathways Leading to Altered Gene Expression and Oncogenic Transformation In Vitro.
    Parfett CL; Desaulniers D
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28587163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose response problems in carcinogenesis.
    Crump KS
    Biometrics; 1979 Mar; 35(1):157-67. PubMed ID: 497333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemical carcinogen mechanisms of action and implications for testing methodology.
    Williams GM; Iatropoulos MJ; Weisburger JH
    Exp Toxicol Pathol; 1996 Feb; 48(2-3):101-11. PubMed ID: 8672863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Constitutive and carcinogen-derived DNA binding as a basis for the assessment of potency of chemical carcinogens.
    Lutz WK
    Adv Exp Med Biol; 1981; 136 Pt B():1349-65. PubMed ID: 7344514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modern criteria to determine the etiology of human carcinogens.
    Mossman BT; Klein G; Zur Hausen H
    Semin Cancer Biol; 2004 Dec; 14(6):449-52. PubMed ID: 15489138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of known human carcinogens.
    Barrett JC
    IARC Sci Publ; 1992; (116):115-34. PubMed ID: 1428078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.